SHINE develops and deploys fusion-based technology to produce medical isotopes and neutron sources. Its processes generate molybdenum-99, a precursor to technetium-99m used in diagnostic imaging, and lutetium-177 for diagnostic and therapeutic use, along with iodine-131 and iodine-125 for thyroid treatment and brachytherapy, and xenon-133 for lung and brain imaging. The company’s systems also provide neutron sources for industrial imaging, radiation-effects testing, and fusion materials research. In addition to medical isotopes, SHINE aims to recycle nuclear waste and advance fusion power as a source of clean energy. The business serves health care and industrial customers worldwide. SHINE is based in Janesville, Wisconsin, with an office in Alkmaar, Netherlands.
Phoenix, LLC, established in 2005 and headquartered in Madison, Wisconsin, specializes in designing and manufacturing high-yield neutron generators and other commercial nuclear technologies. These products cater to diverse applications across industries such as aerospace, defense, medical, and semiconductor, including neutron radiography, cargo screening, medical isotope production, and nuclear fuel scanning. The company's commitment to practical nuclear technologies has also set a long-term goal of contributing to clean, fusion energy production.
Lantheus - SPECT Business
Lantheus - SPECT Business is a unit of Lantheus that provides diagnostic radiopharmaceutical products such as TechneLite®, NEUROLITE®, Xenon Xe-133 Gas, and Cardiolite services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.